Literature DB >> 157977

Aberrant secondary antibody responses to sheep erythrocytes in rabbits with experimental syphilis.

R E Baughn, D M Musher.   

Abstract

Rabbits infected with Treponema pallidum have strikingly depressed in vivo immunoglobulin G responses to sheep erythrocytes. To gain further insight into the nature of this suppression, the immune responses of splenic and peripheral blood lymphocytes from infected rabbits to sheep erythrocytes were studied in vitro. Spleen cells from rabbits that had been sensitized with sheep erythrocytes during active syphilis had greatly decreased immunoglobulin M and G responses after in vitro incubation with sheep erythrocytes, when compared to the results obtained with cells from sensitized uninfected animals. Suppressor cells could be demonstrated in peripheral blood lymphocytes of control rabbits 6 months after sensitization with sheep erythrocytes; these cells could be removed by nylon wool filtration. When primary sensitization with sheep erythrocytes was carried out during active syphilis, these suppressor cells were not detectable in peripheral blood lymphocytes 6 to 9 months later. These findings provide further evidence that induction of immune responses may be abnormal early in treponemal infection and may help to explain the failure of the host to produce antibodies which eradicate the organism during the first 2 to 3 months of infection.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 157977      PMCID: PMC443566          DOI: 10.1128/iai.25.1.133-138.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  The role of antigen-antibody complexes in mediating immunologic unresponsiveness in the chicken.

Authors:  E L Morgan; C H Tempelis
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

2.  Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

3.  Blocking antigen-antibody complexes on the T-lymphocye surface identified with defined protein antigens. II. Lymphocyte activation during the in vitro response.

Authors:  S Kontiainen
Journal:  Immunology       Date:  1975-03       Impact factor: 7.397

4.  Blocking antigen-antibody complexes on the T-lymphocyte activation during in vitro incubation before adoptive transfer.

Authors:  S Kontiainen; N A Mitchison
Journal:  Immunology       Date:  1975-03       Impact factor: 7.397

5.  Depression of the plaque-forming cells to sheep red blood cells by the new-born larvae of Trichinella spiralis.

Authors:  G M Faubert
Journal:  Immunology       Date:  1976-04       Impact factor: 7.397

6.  Altered immune responsiveness associated with experimental syphilis in the rabbit: elevated IgM and depressed IgG responses to sheep erythrocytes.

Authors:  R E Baughn; D M Musher
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

7.  Terminal electron transport in Treponema pallidum.

Authors:  P G Lysko; C D Cox
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

8.  Effect of sensitization with Propionibacterium acnes on the growth of Listeria monocytogenes and Treponema pallidum in rabbits.

Authors:  R E Baughn; D M Musher; J M Knox
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

9.  Mucopolysaccharide material resulting from the interaction of Treponema pallidum (Nichols strain) with cultured mammalian cells.

Authors:  T J Fitzgerald; R C Johnson; E T Wolff
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

10.  Development of of macrophage migration inhibition in rabbits infected with virulent Treponema pallidum.

Authors:  C S Pavia; J D Folds; J B Baseman
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

View more
  9 in total

1.  The inaccessibility of the outer membrane of adherent Treponema pallidum (Nichols strain) to anti-treponemal antibodies, a possible role of serum proteins.

Authors:  J J van der Sluis; M Kant; P C Onvlee; E Stolz
Journal:  Genitourin Med       Date:  1990-06

2.  Isolation and preliminary characterization of circulating immune complexes from rabbits with experimental syphilis.

Authors:  R E Baughn; D M Musher
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

3.  Detection of circulating immune complexes in the sera of rabbits with experimental syphilis: possible role in immunoregulation.

Authors:  R E Baughn; K S Tung; D M Musher
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

4.  Response of syphilitic rabbits to reinfection with homologous and heterologous Treponema pallidum strains.

Authors:  R A Strugnell; S Faine; S Graves
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

5.  Sequential changes in susceptibility to Treponema pallidum of rabbits previously infected with Treponema paraluis-cuniculi.

Authors:  S Graves
Journal:  Br J Vener Dis       Date:  1981-02

6.  A histopathologic and immunologic study of the course of syphilis in the experimentally infected rabbit. Demonstration of long-lasting cellular immunity.

Authors:  S Baker-Zander; S Sell
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

7.  Lymphocyte function in experimental endemic syphilis of Syrian hamsters.

Authors:  O Bagasra; H Kushner; S Hashemi
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

8.  Evaluation of rosaramicin phosphate in treatment of experimental syphilis in rabbits.

Authors:  R E Baughn; D M Musher; C B Adams; J M Knox
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

9.  Reappraisal of lymphocyte responsiveness to concanavalin A during experimental syphilis: evidence that glycosaminoglycans in the sera and tissues interfere ith active binding sites on the lectin and not with the lymphocytes.

Authors:  R E Baughn; D M Musher
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.